SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avian ("Bird") Flu Stocks
NNVC 1.985+5.0%Nov 5 3:58 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (184)11/8/2005 1:26:02 AM
From: cari   of 428
 
Flu Test Comparisons:

From what I remember of what I read about QGEN earlier today, their test would differentiate Avian Flu from other flus, while it seems like QDEL's test is not specific - is that correct?

Non-specific?: "Quidel commands about 48% of the flu-testing market with its Quick Vue test, which detects the presence of the more common influenza A and B viruses in patients' nasal swabs. While the diagnostic test isn't specifically designed to identify bird flu, some researchers have reported success in using Quick Vue to detect the H5N1 strain of the influenza virus as well."


Specific?: QIAGEN, a leading provider of solutions for molecular diagnostics today announced the global launch of two novel test kits for the detection of influenza and the avian flu virus (H5N1). These new and advanced tests for use in humans and animals expand the Company's current leading offering in this area and provide significant advantages:

- Breakthroughs in sensitivity and speed
- Broad detection of virus strains....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext